Kyowa opens door to Japanese market for Biogenex:
This article was originally published in Clinica
Executive Summary
Kyowa Medex has signed a contract securing rights to sell US company Biogenex's range of diagnostics for cancer and infectious diseases in Japan. The move is expected to launch Biogenex into the Japanese market and expand Kyowa's product range, reports Japan Chemical Week.